Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
One study reported that GLP-1 is negatively correlated with body mass index (BMI) and that it appears to increase dentate gyrus neurogenesis based on immunostaining images (Weina et al., 2018)
10.1111/jre.12607 47 ParkO.-J.KimJ.YangJ.YunC.-H.HanS
Making Your Choice So, glutathione vs
One 24-month study indicates that 50% of patients respond favorably
I estimate ~$147M (~25%) of GLP-1 revenue in Q3
In small proof-of-concept phase 2 randomized controlled trials (RCTs) in patients with biopsy-confirmed MASH, liraglutide at 1.8 mg/day for 48 weeks (201), semaglutide at 0.4 mg/day for 72 weeks (202), and tirzepatide at 15 mg/week for 52 weeks (203) have been reported to achieve placebo-corrected percentages of participants meeting the criteria for resolution of MASH without worsening fibrosis by 30% (P = 0.019), 42% (P 10%) may lead to diabetes remission (237)
US$ 22.97
US$ 24.96
US$ 27.44
